In cooperation with FBXL3 (F-box and leucine rich repeat protein 3), CRY2 binds to MYC phosphorylated at threonine 58 and targets it for degradation, thus restricting proliferation in cancer cells [43]. The gene discussed is MYC; the disease is cancer.